China Narcolepsy Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.

    People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.

    This report elaborates on the current development of the Narcolepsy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ligand Pharmaceuticals, Inc (US)

    • Arena Pharmaceuticals, Inc (US)

    • Teva Pharmaceutical Industries Ltd (Israel)

    • BIOPROJET (Paris)

    • Jazz Pharmaceuticals plc (Republic of Ireland)

    • Novartis AG (Switzerland)

    • Graymark Healthcare, Inc (US)

    • Shire (Republic of Ireland)

    • Mylan NV (US)

    By Type:

    • Multiple Sleep Latency Test

    • Polysomnogram

    By Application:

    • Hospitals

    • Retail Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Narcolepsy Market Overview 2018-2029

    • 1.1 China Narcolepsy Industry Development Overview

    • 1.2 China Narcolepsy Industry Development History

    • 1.3 China Narcolepsy Industry Market Size (2018-2029)

    • 1.4 China Narcolepsy Market Analysis by Type from Production Side

      • 1.4.1 China Narcolepsy Production Volume, Production Value and Growth Rate of Multiple Sleep Latency Test (2018-2029)

      • 1.4.2 China Narcolepsy Production Volume, Production Value and Growth Rate of Polysomnogram (2018-2029)

    • 1.5 China Narcolepsy Market Analysis by Application from Consumption End

      • 1.5.1 China Narcolepsy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Narcolepsy Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • 1.6 China Narcolepsy Market Analysis by Region

      • 1.6.1 North China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Narcolepsy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Narcolepsy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Narcolepsy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Narcolepsy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Narcolepsy Market Status and Competition Analysis in 2023

      • 2.2.3 China Narcolepsy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Narcolepsy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Narcolepsy Industry Development

    Chapter 3 NarcolepsyIndustry Chain Analysis

    • 3.1 Narcolepsy Industry Chain

    • 3.2 Narcolepsy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Narcolepsy Market

    • 3.3 Narcolepsy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Narcolepsy Market

    Chapter 4 China Narcolepsy Market, by Type

    • 4.1 China Narcolepsy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Narcolepsy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Narcolepsy Production Volume and Growth Rate, by Type

      • 4.5.1 China Narcolepsy Production Volume and Growth Rate of Multiple Sleep Latency Test

      • 4.5.2 China Narcolepsy Production Volume and Growth Rate of Polysomnogram

    Chapter 5 China Narcolepsy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Narcolepsy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Narcolepsy Market Size and Growth Rate, by Application

      • 5.5.1 China Narcolepsy Market Size and Growth Rate of Hospitals

      • 5.5.2 China Narcolepsy Market Size and Growth Rate of Retail Pharmacies

    Chapter 6 China Narcolepsy Market, by Region

    • 6.1 China Narcolepsy Production Volume and Production Value, by Region

    • 6.2 China Narcolepsy Sales Volume and Sales Value, by Region

    Chapter 7 North China Narcolepsy Market Analysis

    • 7.1 North China Narcolepsy Market, by Type

    • 7.2 North China Narcolepsy Market, by Application

    Chapter 8 Central China Narcolepsy Market Analysis

    • 8.1 Central China Narcolepsy Market, by Type

    • 8.2 Central China Narcolepsy Market, by Application

    Chapter 9 South China Narcolepsy Market Analysis

    • 9.1 South China Narcolepsy Market, by Type

    • 9.2 South China Narcolepsy Market, by Application

    Chapter 10 East China Narcolepsy Market Analysis

    • 10.1 East China Narcolepsy Market, by Type

    • 10.2 East China Narcolepsy Market, by Application

    Chapter 11 Northeast China Narcolepsy Market Analysis

    • 11.1 Northeast China Narcolepsy Market, by Type

    • 11.2 Northeast China Narcolepsy Market, by Application

    Chapter 12 Southwest China Narcolepsy Market Analysis

    • 12.1 Southwest China Narcolepsy Market, by Type

    • 12.2 Southwest China Narcolepsy Market, by Application

    Chapter 13 Northwest China Narcolepsy Market Analysis

    • 13.1 Northwest China Narcolepsy Market, by Type

    • 13.2 Northwest China Narcolepsy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ligand Pharmaceuticals, Inc (US)

        • 14.1.1 Ligand Pharmaceuticals, Inc (US) Company Profile

        • 14.1.2 Ligand Pharmaceuticals, Inc (US) Narcolepsy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Arena Pharmaceuticals, Inc (US)

        • 14.2.1 Arena Pharmaceuticals, Inc (US) Company Profile

        • 14.2.2 Arena Pharmaceuticals, Inc (US) Narcolepsy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Teva Pharmaceutical Industries Ltd (Israel)

        • 14.3.1 Teva Pharmaceutical Industries Ltd (Israel) Company Profile

        • 14.3.2 Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 BIOPROJET (Paris)

        • 14.4.1 BIOPROJET (Paris) Company Profile

        • 14.4.2 BIOPROJET (Paris) Narcolepsy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Jazz Pharmaceuticals plc (Republic of Ireland)

        • 14.5.1 Jazz Pharmaceuticals plc (Republic of Ireland) Company Profile

        • 14.5.2 Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Novartis AG (Switzerland)

        • 14.6.1 Novartis AG (Switzerland) Company Profile

        • 14.6.2 Novartis AG (Switzerland) Narcolepsy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Graymark Healthcare, Inc (US)

        • 14.7.1 Graymark Healthcare, Inc (US) Company Profile

        • 14.7.2 Graymark Healthcare, Inc (US) Narcolepsy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Shire (Republic of Ireland)

        • 14.8.1 Shire (Republic of Ireland) Company Profile

        • 14.8.2 Shire (Republic of Ireland) Narcolepsy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Mylan NV (US)

        • 14.9.1 Mylan NV (US) Company Profile

        • 14.9.2 Mylan NV (US) Narcolepsy Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Narcolepsy Industry Research Conclusions

    • 15.2 Narcolepsy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Narcolepsy Industry Market Size (2018-2029)

    • Figure China Narcolepsy Production Volume, Production Value and Growth Rate of Multiple Sleep Latency Test (2018-2029)

    • Figure China Narcolepsy Production Volume, Production Value and Growth Rate of Polysomnogram (2018-2029)

    • Figure China Narcolepsy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Narcolepsy Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure North China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure Central China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure South China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure East China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Narcolepsy Market Size and Growth Rate from 2018-2029

    • Figure Narcolepsy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Narcolepsy Market Share by Type in 2018

    • Figure China Narcolepsy Market Share by Type in 2023

    • Figure China Narcolepsy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Narcolepsy Production Volume and Growth Rate of Multiple Sleep Latency Test (2018-2023)

    • Figure China Narcolepsy Production Volume and Growth Rate of Polysomnogram (2018-2023)

    • Figure China Narcolepsy Market Share by Application in 2018

    • Figure China Narcolepsy Market Share by Application in 2023

    • Figure China Narcolepsy Total Market Size and Growth Rate from Consumption End

    • Figure China Narcolepsy Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Narcolepsy Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Table China Narcolepsy Production Volume by Region (2018-2023)

    • Table China Narcolepsy Production Volume Share by Region (2018-2023)

    • Figure China Narcolepsy Production Volume Share by Region (2018-2023)

    • Table China Narcolepsy Production Value by Region (2018-2023)

    • Table China Narcolepsy Production Value Share by Region (2018-2023)

    • Figure China Narcolepsy Production Value Share by Region (2018-2023)

    • Table China Narcolepsy Sales Volume by Region (2018-2023)

    • Table China Narcolepsy Sales Volume Share by Region (2018-2023)

    • Figure China Narcolepsy Sales Volume Share by Region (2018-2023)

    • Table China Narcolepsy Sales Value by Region (2018-2023)

    • Table China Narcolepsy Sales Value Share by Region (2018-2023)

    • Figure China Narcolepsy Sales Value Share by Region (2018-2023)

    • Table North China Narcolepsy Production Volume by Type (2018-2023)

    • Table North China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure North China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table North China Narcolepsy Sales Volume by Application (2018-2023)

    • Table North China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure North China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table Central China Narcolepsy Production Volume by Type (2018-2023)

    • Table Central China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure Central China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table Central China Narcolepsy Sales Volume by Application (2018-2023)

    • Table Central China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure Central China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table South China Narcolepsy Production Volume by Type (2018-2023)

    • Table South China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure South China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table South China Narcolepsy Sales Volume by Application (2018-2023)

    • Table South China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure South China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table East China Narcolepsy Production Volume by Type (2018-2023)

    • Table East China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure East China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table East China Narcolepsy Sales Volume by Application (2018-2023)

    • Table East China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure East China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Narcolepsy Production Volume by Type (2018-2023)

    • Table Northeast China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table Northeast China Narcolepsy Sales Volume by Application (2018-2023)

    • Table Northeast China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Narcolepsy Production Volume by Type (2018-2023)

    • Table Southwest China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table Southwest China Narcolepsy Sales Volume by Application (2018-2023)

    • Table Southwest China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Narcolepsy Production Volume by Type (2018-2023)

    • Table Northwest China Narcolepsy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Narcolepsy Production Volume Share by Type (2018-2023)

    • Table Northwest China Narcolepsy Sales Volume by Application (2018-2023)

    • Table Northwest China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Narcolepsy Sales Volume Share by Application (2018-2023)

    • Table Ligand Pharmaceuticals, Inc (US) Company Profile

    • Table Ligand Pharmaceuticals, Inc (US) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Arena Pharmaceuticals, Inc (US) Company Profile

    • Table Arena Pharmaceuticals, Inc (US) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Company Profile

    • Table Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table BIOPROJET (Paris) Company Profile

    • Table BIOPROJET (Paris) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Jazz Pharmaceuticals plc (Republic of Ireland) Company Profile

    • Table Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Novartis AG (Switzerland) Company Profile

    • Table Novartis AG (Switzerland) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Graymark Healthcare, Inc (US) Company Profile

    • Table Graymark Healthcare, Inc (US) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Shire (Republic of Ireland) Company Profile

    • Table Shire (Republic of Ireland) Narcolepsy Revenue, Price and Gross (2018-2023)

    • Table Mylan NV (US) Company Profile

    • Table Mylan NV (US) Narcolepsy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.